Decreased risks for cervical cancer and non-melanomaskincancer were also seen.
2
The global incidence of non-melanomaskincancer is rising.
3
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanomaskincancer worldwide.
4
Objective: To determine the incidence and clinical characteristics of non-melanomaskincancer in Hong Kong Chinese patients.
5
According to the Cancer Council, excluding non-melanomaskincancer, melanoma is the third most common cancer in Australians.
1
Conclusions: Previous definitions of recurrence and surveillance methods after surgical treatment of nonmelanomaskincancer are variable and nonstandard.
2
Purpose: To identify nonmelanomaskincancer patients with squamous cell carcinoma (SCC) who are at greatest risk of disease-specific mortality.
3
However, there is increasing interest in the use of topical alternatives for the prevention and treatment of nonmelanomaskincancer, particularly superficial variants.
4
Objective: The objective of this study was to learn if variations exist in the treatment of nonmelanomaskincancer in different practice settings.
5
A survey of patients with histologically confirmed nonmelanomaskincancer (NMSC) found 12 families in which several members developed skin cancers.
1
Multiple or recurrent squamous cell skincarcinoma is a rare tumor in the aged.
2
This is the first case report of scalp PG with cranial osteolysis in an 80-year-old adult, with an initial presentation mimicking skincarcinoma.
3
Mutations in two homologous genes, EVER1 and EVER2 increase the susceptibility to infection with certain human papillomaviruses resulting in high risk of skincarcinoma.
4
Two reports deal with the treatment of progressive squamous cell skincarcinoma with systemic 5-FU, but in only eight patients age less than 70 years.
5
By contrast, cellular senescence was unable to suppress chemically induced skincarcinomas.
Uso de carcinoma of the skin em inglês
1
One patient developed squamous cell carcinomaoftheskin.
2
Merkel cell carcinomaoftheskin most commonly presents as a single, rapidly growing, flesh-colored, painless mass.
3
There are a number of options available to the physician for the primary management of basal cell and squamous cell carcinomaoftheskin.
4
Immuno-photodynamic therapy may be particularly indicated for squamous cell carcinomaoftheskin, which we show to be strongly positive for markers of angiogenesis.
5
Carcinomasoftheskin, lip, and uterine cervix were successfully treated by conventional techniques.
6
High-dose 13-cis-retinoic acid also has achieved significant activity in preventing invasive carcinomasoftheskin.
7
In January 2012, vismodegib was approved by the FDA for the treatment of unresectable or metastatic basal cell carcinomasoftheskin.
8
Patients develop multiple basal cell carcinomasoftheskin frequently in early life and also have a predisposition to additional malignancies such as medulloblastoma.